Assessment of two-year clinical outcomes after keratoconus treatment using two different crosslinking protocols
M.G. Burcel, I.C. Lacraru, D.M.C. Dascalescu, M.-C. Corbu, V. Potop, V. Coviltir Department of Ophthalmology, City Hospital Videle, Bucharest, Romania. cristea.miruna@yahoo.com
OBJECTIVE: This study aims to compare the long-term outcomes of standard corneal collagen crosslinking with accelerated corneal collagen crosslinking (CXL) for progressive keratoconus.
PATIENTS AND METHODS: This prospective, comparative study included 79 eyes with progressive keratoconus, which were randomly assigned: 42 eyes received a standard CXL procedure, and 37 eyes were treated with the accelerated CXL protocol. We evaluated the following parameters, before the procedure and 1 month, 6 months, 12 months and 24 months postoperatively: best corrected visual acuity (BCVA), manifest refraction spherical equivalent (MRSE), cylindrical values, corneal dioptric powers on the steepest meridian (Kmax), central corneal thickness (CCT); demarcation line depth (DLD) preoperatively and 1 month after the CXL procedure.
RESULTS: The BCVA, MRSE, cylindrical values, Kmax, CCT improved significantly, after both the accelerated and the standard CXL procedure. Throughout the 24-months follow-up, BCVA improvement was achieved sooner in the accelerated group (after 1 month, vs. after 3 months). However, there were no statistically significant differences between the two groups in these aspects. The DLD-to-CCT was significantly greater in the standard group (66% vs. 62%, p = 0.02).
CONCLUSIONS: Standard and accelerated CXL are effective in stabilizing keratoconus progression in the long term. In clinical practice, the accelerated protocol has the added benefit of a faster visual recovery, in addition to the known reduced treatment time and increased comfort.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M.G. Burcel, I.C. Lacraru, D.M.C. Dascalescu, M.-C. Corbu, V. Potop, V. Coviltir
Assessment of two-year clinical outcomes after keratoconus treatment using two different crosslinking protocols
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 3
Pages: 906-916
DOI: 10.26355/eurrev_202202_28000